William Brubaker, MD
Urology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Offices
- 6
Offices
6 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Mills-Peninsula Medical Center · Sequoia Hospital. That is not proof they admit you there this week.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Brubaker’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A138666 · Current
Licensed to practise in California · since 2015 · expires 2027-02-28 · Eastern Virginia Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$166,328
Medicare paid this office $166,328 for 520 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 239 | $28,867 | $82 |
| Return visit (30+ min) | 159 | $26,776 | $115 |
| New patient visit (30+ min) | 239 | $22,974 | $96 |
| Diagnostic exam of bladder and urethra using an endoscope | 53 | $14,564 | $247 |
| Biopsy of prostate gland | 46 | $10,914 | $237 |
See all 14 services
| Short return visit (20+ min) | 239 | $28,867 | $82 |
| Return visit (30+ min) | 159 | $26,776 | $115 |
| New patient visit (30+ min) | 239 | $22,974 | $96 |
| Diagnostic exam of bladder and urethra using an endoscope | 53 | $14,564 | $247 |
| Biopsy of prostate gland | 46 | $10,914 | $237 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 368 | $8,417 | $15 |
| Ultrasound scan of pelvic region through rectum | 51 | $7,616 | $149 |
| Placement of device in prostate for radiation therapy | 12 | $1,807 | $151 |
| Ultrasound measurement of bladder capacity after voiding | 141 | $1,742 | $11 |
| Tissue marker, implantable, any type, each | 11 | $1,139 | $60 |
| 3d radiographic procedure with computerized image postprocessing | 30 | $1,016 | $34 |
| Ultrasonic guidance for needle placement | 11 | $642 | $58 |
| Injection of drug or substance under skin or into muscle | 25 | $475 | $14 |
| Injection, garamycin, gentamicin, up to 80 mg | 44 | $108 | None |
Procedures Medicare counted
| Prostate resection | 15 | More than 70% of doctors who do this |
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
520 Original Medicare patients in 2024. Average age 76 · Women 14% · Also on Medicaid 6% · Health risk score 0.99. At or below the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 62% · Coronary heart disease 30% · Cancer 25% · Chronic kidney disease 24% · Atrial fibrillation 21% · Diabetes 20% · Depression 12% · Heart failure 9% · COPD 5% · Dementia 5% · Stroke 5%.
The office billed $758,098, Medicare allowed $219,123 and paid $166,328; for 2,796 services of 71 kinds; $2,747 of it was for drugs given in the office and $163,581 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 520 | 2,796 | 76 | 0.99 | $758,098 | $166,328 |
| 2023 | 516 | 3,772 | 76 | 0.94 | $793,324 | $200,391 |
| 2022 | 466 | 2,604 | 77 | 1.00 | $728,401 | $173,762 |
| 2021 | 475 | 1,960 | 77 | 1.02 | $688,818 | $161,743 |
| 2020 | 208 | 490 | 76 | 0.95 | $173,593 | $44,580 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Return visit (30+ min) | 191 | $31,955 | $113 |
| Short return visit (20+ min) | 208 | $22,869 | $81 |
| New patient visit (30+ min) | 237 | $21,898 | $92 |
| Diagnostic exam of bladder and urethra using an endoscope | 46 | $12,832 | $252 |
| Waterjet destruction of prostrate accessed through the urethra | 14 | $9,077 | $648 |
| Biopsy of prostate gland | 29 | $7,135 | $246 |
| Insertion of lower leg neurostimulator electrode | 21 | $5,818 | $114 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 13 | $5,131 | $366 |
| Ultrasound scan of pelvic region through rectum | 24 | $3,593 | $150 |
| Ultrasound measurement of bladder capacity after voiding | 158 | $2,135 | $11 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $712 | $42 |
| 3d radiographic procedure with computerized image postprocessing | 14 | $492 | $35 |
| Injection of drug or substance under skin or into muscle | 24 | $373 | $14 |
| Imaging of urinary tract following injection of a contrast agent | 11 | $249 | $23 |
| Injection, garamycin, gentamicin, up to 80 mg | 28 | $69 | None |
2022: 13 services
| Return visit (30+ min) | 170 | $28,227 | $112 |
| New patient visit (30+ min) | 199 | $19,124 | $96 |
| Short return visit (20+ min) | 147 | $16,666 | $83 |
| Insertion of lower leg neurostimulator electrode | 38 | $16,665 | $122 |
| Diagnostic exam of bladder and urethra using an endoscope | 41 | $11,085 | $252 |
| Biopsy of prostate gland | 41 | $9,834 | $240 |
| Ultrasound scan of pelvic region through rectum | 35 | $5,115 | $146 |
| Ultrasound measurement of bladder capacity after voiding | 159 | $2,365 | $11 |
| Simple insertion of temporary bladder tube | 12 | $1,206 | $60 |
| 3d radiographic procedure with computerized image postprocessing | 25 | $882 | $35 |
| Injection of drug or substance under skin or into muscle | 38 | $640 | $14 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $254 | $23 |
| Injection, garamycin, gentamicin, up to 80 mg | 32 | $49 | None |
2021: 15 services
| New patient visit (30+ min) | 189 | $18,688 | $99 |
| Insertion of lower leg neurostimulator electrode | 34 | $17,762 | $133 |
| Short return visit (20+ min) | 149 | $17,345 | $79 |
| Return visit (30+ min) | 116 | $15,651 | $112 |
| Diagnostic exam of bladder and urethra using an endoscope | 42 | $10,305 | $245 |
| New patient visit (45+ min) | 66 | $10,041 | $152 |
| Biopsy of prostate gland | 36 | $8,873 | $246 |
| Ultrasound scan of pelvic region through rectum | 32 | $4,696 | $147 |
| Ultrasound measurement of bladder capacity after voiding | 194 | $2,827 | $10 |
| Simple insertion of temporary bladder tube | 16 | $2,489 | $64 |
| 3d radiographic procedure with computerized image postprocessing | 27 | $967 | $36 |
| Injection of drug or substance under skin or into muscle | 35 | $595 | $14 |
| Electronic assessment of bladder emptying | 28 | $331 | $11 |
| Injection, garamycin, gentamicin, up to 80 mg | 36 | $75 | None |
| Automated urinalysis test | 11 | $25 | $2 |
2020: 8 services
| New patient visit (45+ min) | 58 | $8,418 | $145 |
| Insertion of lower leg neurostimulator electrode | 18 | $7,068 | $133 |
| New patient visit (30+ min) | 65 | $6,314 | $97 |
| Short return visit (20+ min) | 59 | $4,804 | $69 |
| Diagnostic exam of bladder and urethra using an endoscope | 18 | $3,909 | $217 |
| Return visit (30+ min) | 25 | $2,738 | $105 |
| Ultrasound measurement of bladder capacity after voiding | 67 | $820 | $11 |
| Electronic assessment of bladder emptying | 27 | $369 | $14 |
Drugs they prescribed that Part D paid
$114,253
Pharmacies billed $114,253 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,284 generic and 105 brand-name prescriptions · $114,253 in drug cost · 126 antibiotic prescriptions to 74 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 92 | $72,423 | $787 |
| Tamsulosin | 412 | $8,853 | $21 |
| Trospium Chloride | 109 | $5,836 | $54 |
| Finasteride | 214 | $4,127 | $19 |
| Alfuzosin Hcl Er | 161 | $4,091 | $25 |
See all 14 drugs
| Myrbetriq | 92 | $72,423 | $787 |
| Tamsulosin | 412 | $8,853 | $21 |
| Trospium Chloride | 109 | $5,836 | $54 |
| Finasteride | 214 | $4,127 | $19 |
| Alfuzosin Hcl Er | 161 | $4,091 | $25 |
| Solifenacin | 47 | $3,137 | $67 |
| Methenamine Hippurate | 24 | $1,617 | $67 |
| Desmopressin Acetate | 57 | $1,556 | $27 |
| Estradiol | 18 | $1,406 | $78 |
| Potassium Citrate Er | 24 | $1,370 | $57 |
| Oxybutynin Chloride Er | 14 | $464 | $33 |
| Nitrofurantoin | 14 | $429 | $31 |
| Ciprofloxacin | 65 | $194 | $3 |
| Cephalexin | 15 | $67 | $4 |
Year by year
| 2024 | 1,389 | 373 | None | 8% | $114,253 |
| 2023 | 1,166 | 330 | None | None | $98,733 |
| 2022 | 962 | 269 | None | None | $69,235 |
| 2021 | 709 | 234 | None | 7% | $45,854 |
| 2020 | 168 | 96 | None | 7% | $10,233 |
| 2019 | 93 | 71 | 66% (61) | None | $2,347 |
| 2018 | 40 | 39 | 98% (39) | 0% | $141 |
| 2017 | 33 | 30 | 85% (28) | None | $215 |
| 2016 | 56 | 49 | 86% (48) | None | $565 |
| 2015 | 26 | 21 | 73% (19) | None | $407 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Myrbetriq | 74 | $55,167 | $746 |
| Tamsulosin | 338 | $8,568 | $25 |
| Trospium Chloride | 108 | $8,526 | $79 |
| Alfuzosin Hcl Er | 114 | $4,374 | $38 |
| Solifenacin | 42 | $4,107 | $98 |
| Finasteride | 171 | $2,870 | $17 |
| Methenamine Hippurate | 31 | $2,467 | $80 |
| Desmopressin Acetate | 47 | $1,684 | $36 |
| Estradiol | 11 | $1,256 | $114 |
| Oxybutynin Chloride Er | 36 | $1,227 | $34 |
| Terazosin | 15 | $1,130 | $75 |
| Ciprofloxacin | 40 | $138 | $3 |
| Sulfamethoxazole-Trimethoprim | 14 | $97 | $7 |
| Cephalexin | 11 | $71 | $6 |
2022: 16 drugs
| Myrbetriq | 47 | $30,069 | $640 |
| Tamsulosin | 296 | $6,940 | $23 |
| Trospium Chloride | 63 | $6,218 | $99 |
| Trospium Chloride Er | 11 | $3,341 | $304 |
| Solifenacin | 37 | $3,084 | $83 |
| Methenamine Hippurate | 35 | $2,888 | $83 |
| Finasteride | 140 | $2,885 | $21 |
| Dutasteride | 13 | $1,998 | $154 |
| Alfuzosin Hcl Er | 57 | $1,489 | $26 |
| Desmopressin Acetate | 45 | $1,407 | $31 |
| Oxybutynin Chloride Er | 24 | $1,167 | $49 |
| Terazosin | 14 | $1,001 | $71 |
| Ciprofloxacin | 54 | $228 | $4 |
| Cephalexin | 17 | $178 | $10 |
| Cefdinir | 11 | $175 | $16 |
| Sulfamethoxazole-Trimethoprim | 22 | $77 | $4 |
2021: 15 drugs
| Myrbetriq | 41 | $22,176 | $541 |
| Tamsulosin | 202 | $4,209 | $21 |
| Trospium Chloride Er | 17 | $3,218 | $189 |
| Finasteride | 106 | $2,988 | $28 |
| Trospium Chloride | 26 | $2,634 | $101 |
| Oxybutynin Chloride Er | 42 | $1,890 | $45 |
| Desmopressin Acetate | 17 | $1,228 | $72 |
| Solifenacin | 13 | $985 | $76 |
| Terazosin | 13 | $844 | $65 |
| Alfuzosin Hcl Er | 21 | $608 | $29 |
| Amoxicillin-Clavulanate Potass | 11 | $419 | $38 |
| Ciprofloxacin | 51 | $247 | $5 |
| Cephalexin | 24 | $143 | $6 |
| Nystatin | 14 | $126 | $9 |
| Sulfamethoxazole-Trimethoprim | 23 | $119 | $5 |
2020: 4 drugs
| Tamsulosin | 42 | $829 | $20 |
| Oxybutynin Chloride Er | 20 | $623 | $31 |
| Finasteride | 23 | $576 | $25 |
| Ciprofloxacin | 13 | $62 | $5 |
2019: 1 drug
| Tramadol | 54 | $122 | $2 |
2018: 2 drugs
| Hydrocodone-Acetaminophen | 15 | $62 | $4 |
| Tramadol | 19 | $49 | $3 |
2017: 1 drug
| Hydrocodone-Acetaminophen | 21 | $151 | $7 |
2016: 1 drug
| Hydrocodone-Acetaminophen | 38 | $336 | $9 |
2015: 1 drug
| Hydrocodone-Acetaminophen | 15 | $134 | $9 |
Money from drug and device companies
$971 in 2025
| 2025 | 4 | 10 | $425 | $971 |
| 2024 | 1 | 2 | None | $150 |
| 2022 | 3 | 3 | None | $269 |
| 2021 | 4 | 4 | None | $3,277 |
| 2019 | 1 | 2 | None | $61 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Procept Biorobotics | Aquabeam Robotic System | $639 | 7 payments
|
| Boston Scientific | Spaceoar Vue System - 10ml | $159 | 1 payment
|
| Janssen Biotech | Rybrevant | $122 | 1 payment
|
| Davol | Arista | $51 | 1 payment
|
See all 10 published payments
| Procept Biorobotics | Meals · 2025-12-09 | Aquabeam Robotic System | $27 |
| Procept Biorobotics | Meals · 2025-12-08 | Aquabeam Robotic System | $8 |
| Procept Biorobotics | Consulting · 2025-11-12 | Aquabeam Robotic System | $425 |
| Janssen Biotech | Meals · 2025-10-29 | Rybrevant | $122 |
| Procept Biorobotics | Meals · 2025-09-06 | Aquabeam Robotic System | $19 |
| Davol | Meals · 2025-08-25 | Arista | $51 |
| Procept Biorobotics | Meals · 2025-08-12 | Aquabeam Robotic System | $6 |
| Procept Biorobotics | Meals · 2025-05-21 | Aquabeam Robotic System | $128 |
| Procept Biorobotics | Meals · 2025-04-17 | Aquabeam Robotic System | $25 |
| Boston Scientific | Meals · 2025-02-26 | Spaceoar Vue System - 10ml | $159 |
See earlier years (2024, 2022, 2021, 2019)
2024: $150
| Progenics Pharmaceuticals | Pylarify | $150 | 2 payments
|
2022: $269
| PROCEPT BioRobotics | Aquabeam Robotic System | $153 | 1 payment
|
| Dornier MedTech America | Dornier Medtech | $100 | 1 payment
|
| Medtronic | Signia | $16 | 1 payment
|
2021: $3,277
| Intuitive Surgical | Da Vinci Surgical System | $3,000 | 1 payment
|
| Dornier MedTech America | Consumables & Accessories | $224 | 1 payment
|
| Boston Scientific | Spaceoar Vue | $34 | 1 payment
|
| PROCEPT BioRobotics | Aquabeam Robotic System | $20 | 1 payment
|
2019: $61
| Boston Scientific | General Kidney Stone Disease | $61 | 2 payments
|
Professional record
- NPI
- 1518387224
- Licence
- CA 390200000, CA A138666California A138666: Current · expires 2027-02-28
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Urology (208800000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2014-04-21
- NPI last updated
- 2020-06-24
- NPI record certified
- 2020-06-24
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr # 5118, Stanford, CA, 94305